Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
Recruiting
N/A
Interventional Study
HPV Infection
HPV 16 Infection
High Risk HPV
Cervical Cancer Screening
Cervical Cancer Cin Grade
Cervical Cancer (Early Detection)
HPV
HPV (Human Papillomavirus)-Associated
HPV DNA
HPV Infections
Screening Test
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 25 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 450 (estimated)
- Sponsor
- Qurasense · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The EQUIP Study is testing whether high-risk human papillomavirus (hrHPV), the virus that causes most cervical cancers, can be accurately detected from menstrual blood collected at home. People who have been referred for colposcopy after an abnormal Pap or hrHPV test will use the Q-Pad Kit during their period to collect menstrual samples on a special menstrual pad and mail them to a central labora…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* You are 25 years old or older and have an intact cervix.
* You were referred for a colposcopy after an abnormal Pap or HPV screen.
* Your periods come regularly-about every 21-35 days.
* You own a smartphone, have an email address, and can read the Qvin app instructions in Eng…
Contacts